Immunic Therapeutics

📍 New York City, United States🗓 Founded 2016👥 19 employees
Biotechnology🌐 imux.com
Website LinkedIn
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Immunic Therapeutics founded?
Immunic Therapeutics was founded in 2016.
What industry is Immunic Therapeutics in?
Immunic Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Immunic Therapeutics based?
Immunic Therapeutics is headquartered in New York City, United States.